Passage BIO, Inc. - 8-K Filing
Passage Bio stockholders approve merger with Remix Therapeutics, including reverse stock split and new equity incentive plans. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 5.07 Submission of Matters to a Vote of Security Holders, 9.01 Financial Statements and Exhibits)
Tickers: $PASG